返回
BioInvent International AB (publ)（BOVNF）價格
BOVNF 股價走勢圖
BOVNF 財務
BioInvent International AB (publ)
$3.28
0%
$0
收盤價：Jan 28, 16:00:00 GMT-5
$3.28
0%
$0
盤後：Jan 28, 20:22:31 GMT-5
關鍵數據
前收市價
$3.28
開盤價
$4.7
當日範圍
$3.28 - $4.7
52週區間
$3.28 - $4.7
交易量
908
平均成交量
0
每股盈餘 (TTM)
-0.47
股息收益率
--
市值
$216.4M
什麼是 BIOINVENT INTERNATIONAL AB？
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 124 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.